Societe Generale Effekten (S29775) Cotización

60 Days , sixty days to get a solid position , it appears MONI has a long fuse quick flippers will get board and complain .

Looking at the daily volume Continuation Capital probably hasn't even worked through their first 60,200,000 share tranche for fees and expenses yet. Looks like there are buyers in volume for those shares at $0.0015. I would say that there will be all you could ever want available at that price.

So predictable. The 280MM yearly sales projection was never going to be achieved, thus Foley was running out of time.
Now the $6.66 will go down.
I expect to see this case study in a Harvard Business Review someday.

RVNC 3Q24 results (FWIW):

https://investors.revance.com/investors/Press-Releases/news-details/2024/Revance-Reports-Third-Quarter-2024-Financial-Results-Provides-Corporate-Update/default.aspx

• 3Q24 product sales (Daxxify + dermal fillers) were $58.8M, -10% QoQ and +9%

Solid link. A refuge in our hectic day.

Balfour Project drilling, 2022 report, is public information. The Extract at Hiru shows a Comparable transactions analysis--for the shareholder report it is likely for. Other matters appear to be public information for some length of time. It is likely that legal counsel--one or more--is involved

It's about getting favors from the FDA who is run by the government money talks bull sh walks

Is this your proof that the company is scamming us We don't need no proof. The company will supply that for us.
Cause all the 🤥🤡🤡🤡 in the company itself.

Holding them accountable for their own statements isn't negative. It's called accountability. I can't imagine a scenario where any investor wouldn't want that; except for you of course. Keep on begging for your 2's though....

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $PSLV

Silver eyes $50 in 2025 as industrial demand grows and gold-silver ratio narrows
$GLD $GDX $GDXJ $NUGT $BAR $SLV

The thump is getting louder

https://lindemannlaw.ch/insights/litigation-against-credit-suisse-ubs-current-status-and-legal-developments/

Sooner or later they will have to pay out these contracts, termination and close the settlements thoughout the system

Well, so much for that theory. Looks like another three months of short attacks.

totally agree!

In the same section of RVNC’s 10-Q, it says that the Crown acquisition might not go through, which I consider the best-case scenario despite the uncertainty of such an outcome.

WE ARE DOOMED

Honorable Mention, Post-Of-The-Day #2, Must Read.

UK was the right startup environment whilst the FDA will certainly love a nontoxic cure for cancer developed by non BP entity.

I'm happy to take that wager anytime any day. And, I'd be willing wager I'm sitting on substantially more shares than you.

Mr Mister To the best of my knowledge , generic Renvela is the serum pho drug most prescribed to dialysis patient .
It cost about $1 per capsule and most patients need 2-3 with each meal ...so $6- $9 a day ...... max of $270 a month
Most patients don't like Renvela ( it does work

No idea. You’d have to ask the IR guy. You might have better luck than me as apparently he doesn’t even read what I write before replying and telling me to shut up lol. Also don’t tie your carriage to tight to my horse . My query was sincere. I’m not sure if yours are too or you are just a basher.

Honorable Mention, Post-Of-The-Day #1, Must Read.

Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/7/uhqig2_Completed_Cycles.PNG

I will keep my 10 shares and keep an eye on an UNHINGED CEO.